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MinireviewA Convoluted Way to Die
velopment is initiated by transcriptional upregulation ofIvelisse Sa´nchez and Junying Yuan*
Egl-1, another BH3-only member of the BCL-2 familyDepartment of Cell Biology
that acts by inhibiting Ced-9, an antiapoptotic memberHarvard Medical School
of the BCL-2 family (Conradt and Horvitz, 1998).240 Longwood Avenue
BIM may not be the only BH3-only member that isBoston, Massachusetts 02115
induced by trophic factor deprivation. Previously, DP5/
Hrk, another BH3-only member of the BCL-2 family, was
shown to be induced in rat sympathetic neurons upon
NGF deprivation and in cortical neurons stimulated by
The neurons that fail to establish proper connections amyloid b protein (reviewed in Yuan and Yankner, 2000).
with their respective postsynaptic targets die naturally Although it is not clear if inhibition of DP5/Hrk may re-
during development due to the lack of sufficient trophic duce neuronal cell death, coinduction of DP5/Hrk and BIM
support. The first hint that such naturally occurring neu- suggests that multiple BH3-only members of the BCL-2
ronal cell death requires the active participation of neu- family may be induced in order for neurons to die.
rons came from the seminal work by Eugene Johnson The BH3-Only Members of BCL-2 Family: Critical
and colleagues who showed that sympathetic neuronal Intracellular Mediators of Death Signaling
cell death induced by NGF deprivation can be inhibited The BH3-only members of BCL-2 family include Egl-1,
by macromolecular synthesis inhibitors such as cyclo- BIM, Hrk/DP5, BIK, BID BAD, and NOXA, and the list is
heximide and actinomycin D (reviewed in Yuan and Yank- still expanding (Huang and Strasser, 2000). Although
ner, 2000). These findings suggested that certain death- what identifies these killer proteins as a group is only a
inducing molecules must be synthesized in order for limited homology within a stretch of nine–amino acid
neurons to die. The identity of such molecules and how sequence, termed the “BH3 domain,” previous struc-
they function to induce neuronal death have been the tural studies of BID suggest that they may share a sur-
subject of many studies and remained largely a mystery prising high level of homology with other members of
until recently. It turns out that one of these molecules the BCL-2 family in their tertiary structures, consisting
is none other than BIM (the BCL-2 interacting mediator of four hydrophobic a helixes surrounding two central
of cell death), a BH3-only member of the BCL-2 family. hydrophobic helixes, which are the business center of
Previous works from Andrew Strasser’s lab have shown the molecule (Chou et al., 1999; McDonnell et al., 1999).
that there are three BIM isoforms; BIMS, BIML, and BIMEL, Their overall structural similarities indicate that they may
all of which are proapoptotic to different extents (O’Con- act in similar fashion to regulate cell death.
nor et al., 1998). In this issue of Neuron, two papers from Previous works from Johnson’s lab have shown that
the Eugene Johnson and Jonathan Ham laboratories, the protein synthesis step in trophic factor–deprived
respectively (Whitfield et al., 2001; Putcha et al., 2001), sympathetic neurons is required to induce the transloca-
show that BIMEL is induced in a variety of neuronal cell tion of BAX, a proapoptotic member of the BCL-2 family,
death paradigms including sympathetic neurons upon from cytosol to mitochondria, that is critical for neurons
removal of NGF, neonatal sciatic nerve axotomy, and to die (Putcha et al., 1999). Bax2/2 sympathetic neurons
K1-deprived cerebellar granule neurons. Furthermore, are highly resistant to trophic factor deprivation–induced
they show that inhibition of BIM by antisense and ge- cell death (Miller et al., 1997). Therefore, one possibility is
netic knockout approaches significantly reduced sym- that transcriptionally upregulated BIM or BIM-like mole-
pathetic neuron death induced by NGF deprivation. cule(s) are responsible for mitochondrial translocation
Thus, BIM clearly fits the criteria of a death-inducing of BAX. Although it has not been examined whether BAX
molecule that is synthesized in order for neurons to die. remains cytosolic in Bim knockout neurons, Johnson
and colleagues (Putcha et al., 2001) found that inducedUpregulation of BIM expression during apoptosis is
BIM resides in the mitochondria as an integral mem-not limited to neurons: BIM is also induced in cytokine-
brane protein, which makes it unlikely that BIM is re-deprived murine IL3-dependent cells (Shinjyo et al.,
sponsible for the translocation of BAX from the cytosol2001). In addition, BIM is essential for the execution
to mitochondria. Since BIM has been shown to interactof trophic factor deprivation–induced apoptosis in the
with BCL-2 and BCL-W, but not BAX, BIM may functionlymphoid cell lineages (Bouillet et al., 1999). Thus, all
to inactivate BCL-2-related antiapoptotic proteins andtrophic factor deprivation–induced apoptosis in differ-
contribute indirectly to the multimerization and integra-ent mammalian cell types may be regulated by BIM or
tion of BAX into the mitochondrial outer membrane.BIM-like BH3-only members of the BCL-2 family. Since
If BIM does not act by inducing BAX translocation,BIM most likely acts by inhibiting proapoptotic members
then there must be another factor that needs to be syn-of the BCL-2 family (O’Connor et al., 1998), this demon-
thesized in trophic factor–deprived sympathetic neu-strates again the beautiful evolutionary convergence on
rons to induce BAX translocation. Thus, the protein syn-the mechanism of apoptosis from C. elegans to mam-
thesis step in trophic factor–deprived sympatheticmals, as programmed cell death during C. elegans de-
neurons may have produced several death-inducing ac-
tivities that act to coordinate the death process. Interest-
ingly, BID, another BH3-only member of the BCL-2 fam-* To whom correspondence should be addressed (e-mail: jyuan@
hms.harvard.edu). ily that is normally cytosolic in living cells, has been
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shown to induce the conformational change and mito- finger protein that is the terminal global regulator of
somatic sexual fate in C. elegans (Conradt and Horvitz,chondrial translocation of BAX (Eskes et al., 2000). Al-
though it has not yet been shown, it is interesting to 1999). It is not clear, however, which transcriptional fac-
tor positively regulates egl-1 expression in dying cellsspeculate that perhaps a BID-like cytosolic BH3-only
protein(s) may be involved in regulating BAX transloca- in C. elegans.
The expression of BIM, on the other hand, may betion in neurons. BID itself, however, is unlikely to be
involved, as no cleavage of BID was detected during regulated in lymphocytes by FKHR-L1 (Dijkers et al.,
2000), a transcriptional factor whose activity is sup-sympathetic neuronal death (Whitfield et al., 2001).
Multiple Controls of the BH3-Only Killer Activities pressed by the PI3 kinase/Akt pathway. In Ba/F3 cells,
whose survival in culture is IL3 dependent, BIM expres-Regulation of the BH3-only member of the BCL-2 family
can be achieved at both transcriptional and posttran- sion is induced upon IL3 deprivation and also by treat-
ment with PI3 kinase inhibitor. FKHR-L1 has been shownscriptional levels. While Egl-1, BIM, and DP5/Hrk are
regulated at the transcriptional level, BID has been to be a potent inducer of neuronal apoptosis. FKHR-L1
activity is inhibited by Akt-mediated phosphorylation onshown to be regulated by proteolytic cleavage (Li et al.,
1998; Luo et al., 1998). Cleavage of BID by caspase-8 three sites, and IL3 withdrawal resulted in dephosphory-
lation of FKHR-L1. Overexpression of triple mutant ofin the Fas/TNF signaling pathway induces the mitochon-
drial translocation of truncated BID and thereby trans- FKHR-L1, which is unable to be phosphorylated by Akt,
causes cell death in cerebellar granule neurons (Brunetmits the death signal from cytoplasmic membrane to
mitochondria. BAD, on the other hand, has been shown et al., 1999) and induces BIM expression in IL3-main-
tained Ba/F3 cells (Dijkers et al., 2000). Therefore, itto be regulated by protein phosphorylation, which allows
its sequestration by chaperone protein 14-3-3 and inhi- will be very interesting to examine whether FKHR-L1 is
involved in regulating BIM expression in neurons.bition of its proapoptotic activity (Zha et al., 1996).
BIM is not only regulated at the transcriptional level The Signal Transduction Pathway
to BIM Inductionbut also at the postranscriptional level as well. BIM is
normally expressed in hematopoietic, epithelial, neu- Jonathan Ham’s paper (Whitfield et al., 2001) examined
the role of c-Jun in regulating BIM expression in neu-ronal, and germ cells (O’Reilly et al., 2000). In the nervous
system, BIM expression was detected primarily in neu- rons. Activation of c-Jun N-terminal kinase (JNK) and
the phosphorylation of c-Jun are critical events in sym-rons of the gray matter but not in glial cells, astrocytes,
or oligodendrocytes. At the protein level, BIMEL is the pathetic neuronal cell death (reviewed in Yuan and Yank-
ner, 2000). Ham and colleagues showed that expressionpredominant form expressed in neurons. Immunostain-
ing of BIM revealed a punctate pattern, suggesting its of a dominant-negative c-Jun resulted in about 40%
reduction in the levels of BIM expressed in NGF-de-association with cytoplasmic structures. Since expres-
sion of BIM is highly toxic to cells, BIM must be inhibited prived sympathetic neurons. The authors concluded
that the activation of transcriptional factor c-Jun con-in healthy cells. At least one of the known inhibitory
mechanisms is through sequestration to the microtu- tributes to the induction of BIM expression.
c-Jun is activated by phosphorylation with JNK. Usingbule-associated dynein motor complex by direct inter-
action of BIM with LC8 cytoplasmic dynein light chain CEP-1347, a chemical inhibitor of the JNK pathway, but
not JNK itself, Johnson and colleagues showed, judging(Puthalakath et al., 1999). In addition, BIMEL and BIML are
phosphorylated in IL3-dependent hematopoietic cells from their Western blot, that inhibition of JNK pathway
resulted in about similar levels of reduction in BIM ex-upon addition of IL3 by a Ras/Raf/MAPK or Ras/PI3
kinase–dependent mechanism (Shinjyo et al., 2001). pression in NGF-deprived sympathetic neurons as using
the dominant-negative c-Jun mutant as done by theSince the survival of sympathetic neurons in the pres-
ence of NGF is at least partly dependent upon the PI3 Ham group. Thus, both groups are in agreement that
JNK and c-Jun most likely play a role in upregulatingkinase, it is highly likely that constitutively expressed
BIM in sympathetic neurons, albeit at low levels, may BIM expression, but the activation of JNK pathway per
se is not sufficient to induce BIM expression (Whitfieldbe suppressed by phosphorylation as well.
Transcriptional Regulation of the BH3-Only Killers et al., 2001; Putcha et al., 2001).
Johnson and colleagues proposed that trophic factorTranscription is not required for apoptosis induced by
activation of death receptors, such as Fas and TNFR, deprivation–induced sympathetic neuronal cell death
requires the activation of parallel pathways, each ofor by disturbance in cell homeostasis, such as DNA
damage or disruption of cytoskeleton in nonneuronal them is necessary but not sufficient to induce neuronal
cell death. One of the pathways is the induction of BH3-cells. For these types of apoptotic stimuli, the preassem-
bled apoptotic apparatus in cells is fully equipped to only proteins like BIM and DP5/Hrk, which may be nec-
essary for inactivation of BCL-2-like antiapoptotic pro-handle the signal transduction and execution of the
death. Developmental cell death, which may be largely teins and facilitates the mitochondrial translocation of
BAX. The second pathway is the induction of c-Jun anddue to the limiting amount of trophic factors available,
and a number of other cell death paradigms, are unique activation of JNK, which may be necessary for inactivat-
ing a separate antiapoptotic mechanism in neurons,since they require de novo synthesis of death-inducing
molecules to carry out the execution order. The tran- termed “competence-to-die” by Johnson (Deshmukh
and Johnson, 1998). Now we know that the JNK/c-Junscriptional upregulation of egl-1 is critical for the onset of
programmed cell death during C. elegans development pathway also plays a role in the upregulation of BIM.
Thus, the neuronal cell death pathway intertwines at(Conradt and Horvitz, 1998). In C. elegans hermaphro-
dites, the expression of egl-1 is suppressed in a pair of more than one level to coordinate the death process
(Figure 1).hermaphrodite specific neurons, HSN, by Tra-1, a zinc
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Figure 1. The Neuronal Cell Death Pathway
in Sympathetic Neurons
The Overall Picture and Final Thoughts fortunate enough to live free of neurodegenerative dis-
eases. Furthermore, mature neurons are nonprolifera-The current picture of sympathetic neuronal cell death
pathway is as follows (Figure 1). Upon removal of NGF, tive and, therefore, it is unlikely that a defective neuron
may overproliferate and turn cancerous. Thus, the or-neurons induce at least four proteins that may play criti-
cal roles in apoptotic signal transduction: BIM, DP5/Hrk, ganism seems to have adapted an entirely different pol-
icy for neurons: to keep them alive any way it can.and two transcription factors of the AP-1 family—c-Jun
and c-Fos. Because c-Jun is necessary but maybe not What does this complicated neuronal apoptosis path-
way tell us about the therapeutic opportunity of neuro-sufficient to induce BIM expression, c-Jun and another
factor(s) may act together to regulate the expression degenerative diseases? Many studies have demonstrated
that apoptotic mechanisms contribute to both acute andof BIM, DP5/Hrk, or other BH3-like proteins. c-Fos is
unlikely to be involved as its induction is a very late chronic neurodegenerative diseases (Yuan and Yank-
ner, 2000). Inhibition of caspase activation has shownevent. The mechanism by which neurons activate c-Jun
is at least partially through JNK. Activation of JNK is beneficial effects in a number of animal models of neuro-
degenerative models. Convoluted neuronal cell deathcritical for the development of competence-to-die,
which may act by releasing the cytoplasmic “brake” pathways may be good news to us: as multiple control-
ling points in the neuronal death pathways may providefor caspase activation. Upregulated BIM, DP5/Hrk, etc.,
may act to neutralize the neuronal antiapoptotic arse- additional flexibility in choosing the best therapeutic
points. One word of caution, however, is that it remainsnals such as BCL-2 and BCL-xL, thereby facilitating
BAX aggregation and mitochondrial insertion. Thus, the to be seen whether activation of a single neuronal cell
death pathway, which is not sufficient for neurons toneuronal apoptotic pathway is built in such a way to
assure that only when both proapoptotic signaling path- die in short-term culture, can be ignored in the long
term and whether a “half-dead” neuron can be fullyways are activated is the green light to caspase activa-
tion turned on to be swiftly followed by neuronal death. functional. Nevertheless, we have made tremendous
progress in understanding the mechanisms of neuronalThe existing information showed that certain apo-
ptotic pathways, such as death receptor–induced cell cell death in the last decade, and this growing body
of information will very likely help us to develop noveldeath, are incredibly direct: there are very few signal
transduction steps that go from an extracellular death treatments of neurodegenerative diseases in the next
decade.signal to the activation of caspases, which results in the
quick final demise of a cell. In contrast, neurons seem
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